Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNiox Group Regulatory News (NIOX)

Share Price Information for Niox Group (NIOX)

Share Price is delayed by 15 minutes
Get Live Data
61.00    2.00 (3.39%)
Bid:
60.40
Ask:
61.80
Spread: 1.40 (2.318%)
Market Cap: £256.73m
NIOX Live PriceLast checked at - London Stock Exchange

Intraday Niox Group Share Chart

Director/PDMR Shareholding, RPT Update & TVR

25 Oct 2024 17:08

RNS Number : 7500J
Niox Group PLC
25 October 2024
 

NIOX Group plc

(the "Company")

Director/PDMR Shareholding, Related Party Transaction Update

& Total Voting Rights

 

Oxford, UK - 25 October 2024: NIOX Group plc (AIM: NIOX) announces that, Ian Johnson (Executive Chairman), Michael Roller (Chief Financial Officer), Jonathan Emms (Chief Operating Officer), Garry Watts (Non-Executive Director) and Nicholas Mills (Non-Executive Director), (together, the "Directors") notified the Company of their participation in the Company's Tender Offer announced on 24 September 2024.

The resulting interests of each Director are detailed below:

 

Director/PDMR Shareholding

Director/ PDMR

Number of Ordinary Shares held immediately prior to launch of the Tender Offer

Net number of Ordinary Shares sold

Number of Ordinary Shares held in NIOX Group plc as at the date of this announcement

Percentage of voting rights

Ian Roy Johnson

996,825

62,314

934,511

0.23%

Michael Roy David Roller

748,174

46,316

701,858

0.18%

Jonathan Charles Emms

1,005,699

62,353

943,346

0.24%

Garry Watts

477,340

30,162

447,178

0.11%

Nicholas Harwood Bertram Mills

130,000

8,046

121,954

0.03%

 

 

Each of the Directors elected to participate in the Tender Offer in respect of their Basic Entitlements only, however there was an administrative error in calculating the number of shares which were validly tendered by Nicholas Mills. To correct this error, Nicholas Mills purchased 56,933 newly issued Ordinary Shares in the Company (satisfied by an existing block listing) at the Tender Price of 80 pence per share. Further, due to group nominee holdings, the Tender Offer allocation to Ian Johnson and Garry Watts did not fully reflect the Basic Entitlement election and as such a transfer has been made between the individuals at the Tender Price of 80 pence per share to better reflect the expected resultant holdings.

 

Additional detail is provided below in accordance with UK MAR.

 

Related Party Transaction Update

On 17 October 2024, the Company announced that each of Harwood Capital, AstraZeneca plc and Richard Griffiths, Substantial Shareholders in the Company, had tendered at least their Basic Entitlements in the Tender Offer and that this was deemed to constitute related party transactions under AIM Rule 13. The Company has now been notified of their participation in the Tender Offer in the following amounts:

 

Shareholder

Number of Ordinary Shares held before Tender Offer

Ordinary Shares Tendered

Number of Ordinary Shares held post Tender Offer

Percentage of voting rights post Tender Offer

Harwood Capital

75,712,500

5,407,195

70,305,305

17.67%

AstraZeneca plc

71,081,217

4,988,109

66,093,108

16.61%

Richard Griffiths

63,929,400

12,242,250

51,687,150

12.99%

 

As previously stated, the independent Directors, having consulted with the Company's nominated adviser Singer Capital Markets, consider that the terms of the transaction are fair and reasonable insofar as Shareholders are concerned.

 

Total Voting Rights

The Company has 407,980,550 Ordinary Shares in issue, with 397,980,550 Ordinary Shares with voting rights (excluding 10,000,000 shares held in Treasury). This figure of 397,980,550 may be used by the Company's shareholders as the denominator in the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure, Guidance and Transparency Rules.

 

Capitalised terms in this announcement (unless otherwise defined) have the same meanings as set out in the Circular. 

 

Enquiries:

For more information, please visit www.niox.com, or contact:

 

 

NIOX Group plc

Ian Johnson, Executive Chairman

Michael Roller, Chief Financial Officer

 

 

+44 (0) 3303 309 356

 

 

Singer Capital Markets (Nominated Adviser and Joint Broker)

Jen Boorer / James Fischer / James Todd

 

+44 (0) 20 7496 3000

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them:

a)

Name

1. Ian Roy Johnson

2. Michael Roy David Roller

3. Jonathan Charles Emms

4. Garry Watts

5. Nicholas Harwood Bertram Mills

2

Reason for the notification

a)

Position/status

1. Executive Chairman

2. Chief Financial Officer

3. Chief Operating Officer

4. Non-Executive Director

5. Non-Executive Director

b)

Is this an initial notification or an amendment to a prior notification?

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

NIOX Group plc

b)

LEI

2138006YAT138TOGA556

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 0.08p each

 

 

GB00BJVD3B28

b)

Nature of the transaction

Participation in Tender Offer (sale of shares)

c)

 

Price(s) and volume(s)

 

 

 

Price

Volume

1. 80 pence

62,314

2. 80 pence

46,316

3. 80 pence

62,353

4. 80 pence

30,162

5. 80 pence

64,979

 

d)

 

Aggregated information (if any)

 

- Aggregated volume

 

- Price

 N/a

 

 

 

e)

Date of transaction

22.10.2024

f)

Place of the transaction

London Stock Exchange

 

a)

Name

Nicholas Harwood Bertram Mills

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Is this an initial notification or an amendment to a prior notification?

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

NIOX Group plc

b)

LEI

2138006YAT138TOGA556

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 0.08p each

 

 

GB00BJVD3B28

b)

Nature of the transaction

Purchase of newly issued ordinary shares

c)

 

Price(s) and volume(s)

 

 

 

Price

Volume

1. 80 pence

56,933

 

d)

 

Aggregated information (if any)

 

- Aggregated volume

 

- Price

 N/a

 

 

 

e)

Date of transaction

25.10.2024

f)

Place of the transaction

London Stock Exchange

 

 

a)

Name

Ian Roy Johnson

2

Reason for the notification

a)

Position/status

Executive Chairman

b)

Is this an initial notification or an amendment to a prior notification?

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

NIOX Group plc

b)

LEI

2138006YAT138TOGA556

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 0.08p each

 

 

GB00BJVD3B28

b)

Nature of the transaction

Purchase of ordinary shares

c)

 

Price(s) and volume(s)

 

 

 

Price

Volume

2. 80 pence

27,109

 

d)

 

Aggregated information (if any)

 

- Aggregated volume

 

- Price

 N/a

 

 

 

e)

Date of transaction

25.10.2024

f)

Place of the transaction

Off market

 

 

a)

Name

Garry Watts

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Is this an initial notification or an amendment to a prior notification?

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

NIOX Group plc

b)

LEI

2138006YAT138TOGA556

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 0.08p each

 

 

GB00BJVD3B28

b)

Nature of the transaction

Sale of ordinary shares

c)

 

Price(s) and volume(s)

 

 

 

Price

Volume

3. 80 pence

27,109

 

d)

 

Aggregated information (if any)

 

- Aggregated volume

 

- Price

 N/a

 

 

 

e)

Date of transaction

25.10.2024

f)

Place of the transaction

Off market

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHPPGCUUUPCGQA
Date   Source Headline
1st Jun 20261:51 pmRNSTotal Voting Rights
29th May 20263:57 pmRNSDirector/PDMR Shareholding
21st May 20262:47 pmRNSResult of AGM
21st May 20267:00 amRNSAGM Statement
5th May 20264:22 pmRNSGrant of SAYE options
1st May 20264:46 pmRNSTotal Voting Rights
24th Apr 20265:20 pmRNSDividend Timetable
21st Apr 202612:18 pmRNSDirector/PDMR Shareholding
21st Apr 202610:23 amRNSNotice of 2026 Annual General Meeting
17th Apr 20265:59 pmRNSExercise of Options, Director Dealing and TVR
9th Apr 20261:55 pmRNSGrant of Options
1st Apr 20267:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
24th Mar 20263:22 pmRNSHolding(s) in Company
24th Mar 20267:00 amRNSFinal Results
16th Mar 20264:30 pmRNSBlock Listing Application
27th Feb 20269:41 amRNSTotal Voting Rights
30th Jan 202610:04 amRNSTotal Voting Rights
21st Jan 20265:28 pmRNSHolding(s) in Company
20th Jan 20267:00 amRNSFull Year Trading Update
16th Jan 20268:15 amRNSReplacement: Block Listing Application
16th Jan 20267:00 amRNSBlock Listing Application
31st Dec 20259:47 amRNSTotal Voting Rights
31st Dec 20259:47 amRNSTotal Voting Rights
4th Dec 20257:00 amRNSDirector/PDMR Shareholding
1st Dec 202510:29 amRNSHolding(s) in Company
26th Nov 202511:52 amRNSBlock Listing Application
31st Oct 20252:24 pmRNSTotal Voting Rights
8th Oct 20251:08 pmRNSHolding(s) in Company
2nd Oct 20252:11 pmRNSHolding(s) in Company
1st Oct 20253:55 pmRNSBlock listing Interim Review
1st Oct 20253:00 pmRNSTotal Voting Rights
30th Sep 20257:00 amRNSINTERIM RESULTS
19th Sep 20252:16 pmRNSHolding(s) in Company
1st Sep 20253:41 pmRNSTotal Voting Rights
12th Aug 202512:21 pmRNSHolding(s) in Company
6th Aug 202510:35 amRNSHolding(s) in Company
1st Aug 20257:00 amRNSTotal Voting Rights
22nd Jul 20251:48 pmRNSPDMR/PCA Shareholding
8th Jul 20257:00 amRNSTrading Update
26th Jun 20254:15 pmRNSDirector/PDMR Shareholding
25th Jun 20253:45 pmRNSHolding(s) in Company
25th Jun 202510:30 amRNSHolding(s) in Company
17th Jun 202511:45 amRNSHolding(s) in Company
2nd Jun 20257:00 amRNSTotal Voting Rights
28th May 20251:19 pmRNSHolding(s) in Company
27th May 202510:00 amRNSChange of Adviser
23rd May 202510:22 amRNSHolding(s) in Company
21st May 20255:15 pmRNSHolding(s) in Company
21st May 20255:15 pmRNSBlock Listing Application
21st May 20255:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.